Spine BioPharma Revenue and Competitors

Location

#3856

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Spine BioPharma's estimated annual revenue is currently $1.3M per year.(i)
  • Spine BioPharma's estimated revenue per employee is $77,500
  • Spine BioPharma's total funding is $23M.

Employee Data

  • Spine BioPharma has 17 Employees.(i)
  • Spine BioPharma grew their employee count by 6% last year.

Spine BioPharma's People

NameTitleEmail/Phone
1
Chief Commercial Officer & Chief Operating OfficerReveal Email/Phone
2
VP CommercialReveal Email/Phone
3
ControllerReveal Email/Phone
4
VP Patient AccessReveal Email/Phone
5
Director, Finance & AccountingReveal Email/Phone
6
Chairman & CEOReveal Email/Phone
7
Executive Assistant To CEOReveal Email/Phone
8
Clinical Operations AssociateReveal Email/Phone
9
Chairman & CEOReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M4-20%N/AN/A
#2
$6.7M438%N/AN/A
#3
$34.4M222-1%N/AN/A
#4
$5.2M670%$10MN/A
#5
$2M130%N/AN/A
#6
$7.5M370%$51.6MN/A
#7
$0.3M2-50%N/AN/A
#8
$4.3M21-16%$3.3MN/A
#9
$3.6M230%N/AN/A
#10
$4.3M56-8%$118MN/A
Add Company

What Is Spine BioPharma?

Patients around the world are struggling with debilitating back pain, trying to avoid invasive surgeries and the potential of opioid addiction. Spine Biopharma has developed a non-surgical solution that will remove pain and restore functionality, without having to use opioids.

keywords:N/A

$23M

Total Funding

17

Number of Employees

$1.3M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Spine BioPharma News

2022-04-06 - Yuhan's licensed-out disc treatment to go on Phase 3 trial in US

U.S.-based Spine BioPharma has been given permission from the U.S. Food and Drug Administration to bypass the second phase and go directly...

2022-03-22 - Spine BioPharma Completes Series B Financing

Spine BioPharma specializes in non-surgical therapies that will reduce pain, restore function and slow or stop pathological spinal disease...

2022-03-22 - Money on the Move: March 23-29

Spine Biopharma completed a $13 million round of Series B equity financing this week. The financing will support the development of Spine's...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.5M17-62%N/A
#2
$1.5M17-11%N/A
#3
$2.1M17-26%N/A
#4
$4.9M17-19%$19.4M
#5
$7.5M17-19%$56.6M